Harness and gain visibility into the value of multidisciplinary cancer care
Expand Value from Quality Efforts and Simplify Accreditation
Your Quality Efforts Fuel Program Excellence and Brand Eminence
The quality of your cancer program goes beyond a single meeting and extends across the entire patient journey. With OncoLens, cancer centers can drive an average 50 percent improvement in key quality metrics including:
33% increase in number of cases discussed/session
50% increase in patient access to a multi-disciplinary discussion
50% increase in physician engagement/month
25% increase in quality review per case
Benefits extend to all aspects of care including the ability to track and drive improvements in the:
Time from diagnosis to case review
Percentage of patients with biomarker testing and results at the time of initial treatment planning
Number of patients referred to clinical trials
Time from case review and treatment planning to treatment initiation
Number of multidisciplinary team discussions during treatment
Number of patients referred to key services and specialty therapies
The ability to enable quality improvements drives program excellence and is a primary contributor to broader, industry-wide recognition of the cancer center, its affiliates, and available therapies. Becoming a center-of-excellence amplifies brand awareness and helps increase patient-led referrals into your program.
Key metrics that define your cancer service line are embedded within your data. By assessing metrics such as time to treatment, clinical trial accruals and patients accessing key services, you can understand where your cancer center stands against your competition and where you stand in your efforts to gain or maintain quality accreditation.
OncoLens Analyze enables:
Automated reporting for CoC, NAPBC and NAPRC
Continuing Medical Education reports
Metrics and custom reporting for:
Processes such as time to first visit or time to treatment
Appropriateness of Care such as percentage of patients accessing nutritional counseling or speech evaluation
Outcomes and quality such as chemo related ED visits
Results of a Multi-State, Multi-Institution Implementation of OncoLens
Through an analysis of 8,000 providers across the US and more than 13,700 patient cases, it was determined that OncoLens enables cancer programs to effectively collect quality metrics for cancer program accreditation by the American College of Surgeons.
Eighty percent of the case presentations were prospective. And participating cancer centers saw a 65 to 90% reduction in time spent for case preparation.
Benefits of the OncoLens platform included:
increased patient access to multidisciplinary cancer care
increased total cases discussed per conference
increased provider engagement and attendance
improved quality tracking for the Commission on Cancer (CoC) and National Accreditation Program for Breast Centers (NAPBC)
Simplify Accreditation and Ongoing Reporting
Seamless Accreditation Adherence and Tracking
With an increasing number of cancer cases, accreditation requirements and quality improvement guidelines, today’s cancer centers are challenged to measure, monitor and report on multiple quality measures. OncoLens integrates quality requirements natively into the workflow. For each case, the appropriate accreditation requirements are displayed, documented, and tracked. Reporting is simplified to a few clicks. And visibility into adherence is enhanced.
With OncoLens, cancer programs have a powerful tool to:
Capture accreditation and quality measures as part of the tumor board/cancer conference and survivorship care planning process
Leverage custom and standardized reporting templates that prompt users to consider multiple quality measures while developing treatment plans
Reduce the administrative burden of collating data for reporting
Easily generate required reports directly from the OncoLens system
Simplified Accreditation and Data Reporting Capabilities
Maintaining accreditation and achieving quality improvement goals are fundamental challenges every cancer center administrator struggles to address. With OncoLens’ analytic engine and data reporting capabilities, you can easily download the reports that the CoC, NAPBC, and National Accreditation Program for Rectal Cancer (NAPRC) program require for accreditation.
The system captures data directly from the tumor board/cancer conference using smart forms. These interactive tools make sure everything is covered properly and that the majority of the work gets done as the conference and care planning take place.
Measure and aggregate accreditation or custom quality metrics
Download reports that can be ad-hoc or accreditation specific Communicate care pathways
Eliminate the need for manual and duplicate data entry for CoC accreditation reporting
Include metrics and prompts during tumor board to drive behavior
Communicate care pathways and evidence-based guidelines to drive improved quality
Collaborate and coordinate across multi-disciplinary care teams
Get a Step Closer to Real‑time Abstraction
OncoLens delivers seamless integration into cancer registry software to accelerate the identification and intake of new cancer cases for abstracting.
Data collected by OncoLens is imported directly into your registry software at any time—immediately after each tumor board or cancer conference, at set intervals, in batches based on tumor type—based on your workflow. Ascension Saint Thomas recently reported that the OncoLens integration into CRStar delivered a “Ready to Abstract” percentage of over over 80 percent.
OncoLens Integration with Registry Software
Helps you avoid double data entry into the cancer registry
Eases reporting: registry reportable cases in OncoLens can be downloaded into a NAACCR report for upload into registry software
Delivers the data you need in one consolidated upload including clinical data such as staging, prior treatments, and treatment decisions from cancer conference
Ready to Learn More?
Want to learn more about OncoLens solutions? Reach out to us and schedule a demo. See how OncoLens can bring multidisciplinary cancer care into focus.